000 01744 a2200505 4500
005 20250517112913.0
264 0 _c20180222
008 201802s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.11512
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZom, Gijs G
245 0 0 _aTLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.
_h[electronic resource]
260 _bOncotarget
_cOct 2016
300 _a67087-67100 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aFemale
650 0 4 _aHuman papillomavirus 16
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aLymph Nodes
_ximmunology
650 0 4 _aLymphocyte Activation
650 0 4 _aOncogene Proteins, Viral
_ximmunology
650 0 4 _aRepressor Proteins
_ximmunology
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aToll-Like Receptor 2
_ximmunology
650 0 4 _aUterine Cervical Neoplasms
_ximmunology
700 1 _aWelters, Marij J P
700 1 _aLoof, Nikki M
700 1 _aGoedemans, Renske
700 1 _aLougheed, Sinéad
700 1 _aValentijn, Rob R P M
700 1 _aZandvliet, Maarten L
700 1 _aMeeuwenoord, Nico J
700 1 _aMelief, Cornelis J M
700 1 _ade Gruijl, Tanja D
700 1 _aVan der Marel, Gijsbert A
700 1 _aFilippov, Dmitri V
700 1 _aOssendorp, Ferry
700 1 _aVan der Burg, Sjoerd H
773 0 _tOncotarget
_gvol. 7
_gno. 41
_gp. 67087-67100
856 4 0 _uhttps://doi.org/10.18632/oncotarget.11512
_zAvailable from publisher's website
999 _c26363203
_d26363203